Antifungal and Antibiofilm Activity of Bacillus velezensis BP1 Extract Against Candida albicans: In Vitro Bioassay, Metabolomics, In Silico Molecular Docking
DOI:
https://doi.org/10.48048/tis.2025.9971Keywords:
Candida albicans, Bacillus velezensis BP1, Antifungal, Antibiofilm, Metabolomic profiling, Molecular dockingAbstract
The biofilm-forming fungus Candida albicans is a leading cause of candidiasis disease, a condition complicated by the organism’s notable resistance to antifungal treatments. While previous studies have identified various antifungal compounds produced by Bacillus velezensis, the antibiofilm efficacy of these compounds against C. albicans has not been thoroughly explored. This study presents a novel investigation into the secondary metabolites of B. velezensis BP1, focusing specifically on their dual action as antifungal agents and antibiofilm agents against C. albicans. Unlike earlier research that primarily examined the antifungal properties of Bacillus species in isolation, this study employs a comprehensive approach that integrates in vitro antifungal and antibiofilm activity assessments, metabolomic profiling, and in silico molecular docking analyses targeting proteins involved in biofilm formation. This multifaceted methodology allows for a deeper understanding of how BP1-P (biomass) and BP1-S (supernatant) extract from B. velezensis BP1 interact with C. albicans, revealing their capacity to inhibit biofilm formation through structural damage to the fungal hyphae (inhibition of proliferation) as concentrations increase (25 - 400 μg mL−1). This research identifies 4 specific metabolites, betaine, oleamide, l-phenylalanine, and l-pyroglutamic acid that exhibit antifungal properties and demonstrate binding affinity to target proteins associated with biofilm development. The use of advanced imaging techniques such as scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) further distinguishes this study by providing visual confirmation of the morphological changes induced by treatment with BP1 extracts. Thus, BP1-P and BP1-S extract from B. velezensis BP1 can act as an effective antifungal and antibiofilm against C. albicans.
HIGHLIGHTS
- velezensis BP1 extract shows antifungal and antibiofilm activity against C. albicans
- Metabolomics strategy gives an insight into the antibiofilm effects of velezensis BP1 extract
- Betaine, oleamide, l-phenylalanine, and l-pyroglutamic compounds identified
- Molecular docking proves antibiofilm activity against albicans
GRAPHICAL ABSTRACT
Downloads
References
K Kainz, MA Bauer, F Madeo and D Carmona-Gutierrez. Fungal infections in humans: The silent crisis. Microbial Cell 2020; 7(6), 143-145.
IU Macias-Paz, S Pérez-Hernández, A Tavera-Tapia, JP Luna-Arias, JE Guerra-Cárdenas and E Reyna-Beltrán. Candida albicans the main opportunistic pathogenic fungus in humans. Revista Argentina de Microbiología 2023; 55(2), 189-198.
J Talapko, M Juzbašić, T Matijević, E Pustijanac, S Bekić, I Kotris and I Škrlec. Candida Albicans - the virulence factors and clinical manifestations of Infection. Journal of Fungi 2021; 7(2), 79.
S Desrini, M Girardot, C Imbert, M Mustofa and T Nuryastuti. Screening antibiofilm activity of invasive plants rowing at the slope Merapi mountain, central Java, against Candida albicans. BioMed Central Complementary Medicine and Therapies 2023; 23(1), 232.
M Cavalheiro and MC Teixeira. Candida biofilms: Threats, challenges, and promising strategies. Frontiers in Medicine 2018; 5, 28.
RM Pereira, D Sandri, GFA Rios and DAO Sousa, Automation of irrigation by electronic tensiometry based on the arduino hardware platform. Revista Ambiente & Água 2020; 15(4), 1-12.
W Wang, J Zhao and Z Zhang. Bacillus metabolites: Compounds, identification and anti-Candida albicans mechanisms. Microbiology Research 2022; 13(4), 972-984.
SS Chew, LTH Tan, JWF Law, P Pusparajah, BH Goh, NSA Mutalib and H Lee. Targeting gut microbial biofilms: A key to hinder colon carcinogenesis. Cancers 2020; 12(8), 2272.
S Singh and R Shalini. Effect of hurdle technology in food preservation: A review. Critical Reviews in Food Science and Nutrition 2014; 56(4), 641-649.
C Nannan, HQ Vu, A Gillis, S Caulier, TTT Nguyen and J Mahillon. Bacilysin within the Bacillus subtilis group: Gene prevalence versus antagonistic activity against gram-negative foodborne pathogens. Journal of Biotechnology 2021; 327, 28-35.
D Miljaković, J Marinković and S Balešević-Tubić. The significance of Bacillus spp. In disease suppression and growth promotion of field and vegetable crops. Microorganisms 2020; 8(7), 1037.
C Tran, IE Cock, X Chen and Y Feng. Antimicrobial Bacillus: Metabolites and their mode of Action. Antibiotic 2022; 11(1), 88.
LK Caesar, R Montaser, NP Keller and NL Kelleher. Metabolomics and genomics in natural products research: Complementary tools for targeting new chemical entities. Natural Product Reports 2021; 38(11), 2041-2065.
X Chu, M Jaeger, J Beumer, OB Bakker, R Aguirre-Gamboa, M Oosting, SP Smeekens, S Moorlag, VP Mourits, VACM Koeken, CD Bree, T Jansen, IT Mathews, K Dao, M Najhawan, JD Watrous, I Joosten, S Sharma, HJPM Koenen, S Withoff, …, Y Li. Integration of metabolomics, genomics, and immune phenotypes reveals the causal roles of metabolites in disease. Genome Biology 2021; 22(11), 198.
G Chen, AJ Seukep and M Guo. Recent advances in molecular docking for the research and discovery of potential Marine Drugs. Marine Drugs 2020; 18(11), 545.
H Nirwati, E Damayanti, EN Sholikhah, M Mutofa and J Widada. Soil-derived Streptomyces sp. GMR22 producing antibiofilm activity against Candida albicans: bioassay, untargeted LC-HRMS, and gene cluster analysis. Heliyon 2022; 8(4), 09333.
MD Rakhmawatie, N Marfuati, B Barsaliputri, AZ Fikriyah and SN Ethica. Antibacterial activity and GC-MS profile of secondary metabolites of Bacillus subtilis subsp. subtilis HSFI-9 associated with Holothuria scabra, Biodiversitas. Journal of Biological Diversity 2023; 24(5), 2843-2849.
F Masmoudi, NS Pothuvattil, S Tounsi, I Saadaoui and M Trigui. Synthesis of silver nanoparticles using Bacillus velezensis M3-7 lipopeptides: Enhanced antifungal activity and potential use as a biocontrol agent against Fusarium crown rot disease of wheat seedlings. International Journal of Food Microbiology 2023; 407, 110420.
Y Dabiré, NS Somda, CS Compaoré, I Mogmenga, MK Somda, AS Ouattara, MH Dicko, JO Ugwuanyi, LI Ezeogu and AS Traoré. Molecular screening of bacteriocin-producing Bacillus spp. isolated from Soumbala, a fermented food condiment from Parkia biglobosa seeds. Scientific African 2021; 12, 00836.
RH Liu, ZC Shang, TX Li, MH Yang and LY Kong. In vitro antibiofilm activity of eucarobustol E against Candida albicans. Antimicrobial Agents and Chemotherapy 2017; 61(8), 02707-02716.
D Kowalczuk and M Pitucha. Application of FTIR method for the assessment of immobilization of active substances in the matrix of biomedical materials. Materials 2019; 12(18), 2972.
I Shahid, J Han, S Hanooq, KA Malik, CH Borchers and S Mehnaz. Profiling of metabolites of Bacillus spp. and their application in sustainable plant growth promotion and biocontrol. Frontiers in Sustainable Food Systems 2021; 5, 605195.
YS Ahrabi and SN Khoei. Investigation of some natural products as an inhibitor of Agglutinin-Like Sequence (Als3) from Candida albicans (Skin Candidiasis): An in-silico study. Journal of Skin and Stem Cells 2023; 10(4), 142360.
D Sharma, L Misba and AU Khan. Antibiotics versus biofilm: An emerging battleground in microbial communities, antimicrobial resistance & amp. Infection Control and Hospital Epidemiology 2019; 8, 76.
I Martin, V Waters and H Grasemann. Approaches to targeting bacterial biofilms in cystic fibrosis airways. International Journal of Molecular Sciences 2021; 22(4), 2155.
V Amann, AK Kissmann, M Krämer, I Krebs, JA Perez-Erviti, AJ Otero-Gonzalez, F Morales-Vicente, A Rodríguez, L Ständker, T Weil and F Rosenau. Increased activities against biofilms of the pathogenic yeast Candida albicans of optimized Pom-1 derivatives. Pharmaceuticals 2022; 14(2), 318.
Y Cai, C Zhai, X Yu, Y Sun, J Xu, Y Zheng, Y Cong, Y Li, A Chen, H Xu, S Wang and X Wu. Quantitative characterization of water transport and wetting patterns in coal using LF-NMR and FTIR techniques. Fuel 2023; 350, 128790.
W Zhang, A Fina, G Ferraro and R Yang. FTIR and GCMS analysis of epoxy resin decomposition products feeding the flame during UL 94 standard flammability test: Application to the understanding of the blowing-out effect in epoxy/polyhedral silsesquioxane formulations. Journal of Analytical and Applied Pyrolysis 2018; 135, 271-280.
OB Akpor, OD Akinwusi and TA Ogunnusi. Production, characterization and pesticidal potential of Bacillus species metabolites against sugar ant (Camponotus consobrinus). Heliyon 2021; 7(11), 08447.
ASA Al-Thubiani, YA Maher, A Fathi, MAS Abourehab, M Alarjah, MSA Khan and SB Al-Ghamdi. Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megateriumstrain isolated from oral microflora. Saudi Pharmaceutical Journal 2018; 26(8), 1089-1097.
J Cardoso, DG Nakayama, E Sousa and E Pinto. Marine-derived compounds and prospects for their antifungal application. Molecules 2020; 25(24), 5856.
L Camaioni, B Ustyanowski, M Buisine, D Lambert, B Sendid, M Billamboz and S Jawhara. Natural compounds with antifungal properties against Candida albicans and identification of Hinokitiol as a promising antifungal drug. Antibiotics 2023; 12(11), 1603.
G Adwan, Y Salameh, K Adwan and A Barakat. Assessment of antifungal activity of herbal and conventional toothpastes against clinical isolates of Candida albicans. Asian Pacific Journal of Tropical Biomedicine 2012; 2(5), 375-379.
P Scano, MB Pisano, A Murgia, S Cosentino and P Caboni. GC-MS metabolomics and antifungal characteristics of autochthonous Lactobacillus strains. Dairy 2021; 2(3), 326-335.
Q Peng, J Yang, Q Wang, H Suo, AM Hamdy and J Song. Antifungal effect of metabolites from a new strain Lactiplantibacillus Plantarum LPP703 isolated from naturally fermented Yak Yogurt. Foods 2023; 12(1), 181.
MK Patel, D Maurer, O Feygenberg, A Ovadia, Y Elad, M Oren-Shamir and N Alkan. Phenylalanine: A promising inducer of fruit resistance to postharvest pathogens. Foods 2020; 9(5), 646.
L Ai, S Fu, Y Li, M Zuo, W Huang, J Huang, Z Jin and Y Chen. Natural products-based: Synthesis and antifungal activity evaluation of novel L-pyroglutamic acid analogues. Frontiers in Plant Science 2022; 13, 1102411.
FEZ Fathy, Y Ahmed and SA Salam. Hyphal wall protein 1 gene and biofilm formation among Candida albicans isolates from Ain Shams University Hospitals. Egyptian Journal of Medical Microbiology 2023; 32(1), 163-168.
AT Permata, AA Prasetyo and S Haryati. Molecular analysis of Candida albicans Secreted Aspartyl Proteinase 3 (SAP3) Indonesian isolate. IOP Conference Series: Materials Science and Engineering 2018; 434, 012112.
EM Terefe and A Ghosh. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of phytochemicals isolated from Croton dichogamus against the HIV-1 reverse ranscriptase. Bioinformatics and Biology Insights 2022; 16, 11779322221125605.
FA Ugbe, GA Shallangwa, A Uzairu and I Abdulkadir. Molecular docking screening and pharmacokinetic studies of some Boron-Pleuromutilin analogues against possible targets of Wolbachia pipientis. Journal of Molecular Docking 2022; 2(1), 29-43.
M Yildirim and I Celik. Applications of molecular docking studies in SARS-CoV-2 targeted drug discovery and the gains achieved through molecular docking. IntechOpen, London, 2024.
H Hamzah, T Nuryastuti, W Rahmah, L Chabib, ES Syamsul, D Lestari, A Jabbar and SUT Pratiwi. Molecular docking study of the C-10 Massoia Lactone compound as an antimicrobial and antibiofilm agent against Candida tropicalis. The Scientific World Journal 2023; 2023, 6697124.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
